Campbell, CA, United States of America

Rhea Donley

This inventor holds 1 USPTO granted patent. Top assignee: Alza Corporation. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rhea Donley. Retrieved from https://idiyas.com/inventor/rhea-donley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rhea Donley: Innovator in Controlled Release Formulations

Introduction

Rhea Donley is a notable inventor based in Campbell, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. Her work has the potential to improve patient treatment outcomes through innovative drug delivery systems.

Latest Patents

Rhea Donley holds a patent for "Controlled release compositions of tizanidine." This invention relates to novel controlled release formulations of tizanidine, which are designed to enhance the therapeutic effects of the drug. The patent also outlines methods for using these formulations to treat patients effectively.

Career Highlights

Rhea Donley is associated with Alza Corporation, a company known for its advancements in drug delivery technologies. Her role at Alza Corporation has allowed her to focus on innovative solutions that address critical healthcare needs. With her expertise, she has contributed to the development of formulations that can significantly impact patient care.

Collaborations

Rhea has collaborated with esteemed colleagues such as Scott Bull and Suneel K Gupta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.

Conclusion

Rhea Donley's work in controlled release formulations exemplifies the impact of innovation in the pharmaceutical industry. Her contributions not only advance scientific knowledge but also hold promise for improving patient treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…